???global.info.a_carregar???
Miguel Tábuas-Pereira é um neurologista dedicado a alterações cognitivas e comportamentais, sendo o actual co-responsável da consulta de Demências dos CHUC. Dedica-se a demências degenerativas: doença de Alzheimer, Demência Frontotemporal e Demência de Corpos de Lewy, em todas as suas fases - desde a fase pré-sintomática, defeito cognitivo ligeiro ou demência. Embora interessado em todo o espectro de conhecimento nesta área, foca-se nos biomarcadores diagnósticos e prognósticos. Actualmente, dedica o seu doutoramento a alterações genéticas associadas a estas demências. Publicou 100 artigos em revistas especializadas. Participou em 15 ensaios clínicos.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Miguel Tábuas-Pereira

Nomes de citação

  • Tábuas-Pereira, Miguel
  • Miguel Pereira

Identificadores de autor

Ciência ID
1612-623C-B763
ORCID iD
0000-0002-3988-614X
Google Scholar ID
zu-bUQkAAAAJ&hl

Endereços de correio eletrónico

  • 10463@chuc.min-saude.pt (Profissional)

Telefones

Telemóvel
  • 913166131 (Pessoal)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Neurociências
  • Ciências Médicas e da Saúde - Medicina Básica - Genética Humana

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador independente (B1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Português Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Espanhol; Castelhano Utilizador elementar (A1) Utilizador proficiente (C1) Utilizador elementar (A1) Utilizador independente (B1)
Italiano Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1)
Francês Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2015/09/01 - 2021/06/02
Concluído
 Clinical Neurology (Postgraduate Certificate)
University College London Institute of Neurology, Reino Unido
2017/10/01 - 2021/06/01
Em curso
 Medicina (Doutoramento)
Especialização em Neurociências
Universidade de Coimbra Faculdade de Medicina, Portugal
"Genetic characterization and genotype-phenotype correlation of a dementia cohort from central Portugal" (TESE/DISSERTAÇÃO)
2005/10/01 - 2011/07/05
Concluído
 Medicina (Mestrado integrado)
Universidade de Coimbra Faculdade de Medicina, Portugal
 15.5
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2020/09/01 - Atual Professor Auxiliar Convidado (Docente Universitário) Universidade de Coimbra Faculdade de Medicina, Portugal
Universidade de Coimbra Faculdade de Medicina, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2013/01/02 - Atual Assistente (Médica) Centro Hospitalar e Universitário de Coimbra EPE, Portugal
Projetos

Bolsa

Designação Financiadores
2020/05/15 - 2025/04/30 Alzheimer's disease genetic architecture in the Portuguese population
R01AG067426
Bolseiro de Doutoramento
Van Andel Research Institute, Estados Unidos
 National Institute on Aging Division of Aging Biology
Em curso
2020/01/01 - 2024/12/31 Testing Transthyretin (TTR) stability as a key factor in TTR/A-Beta interaction in vivo- use of TTR stabilizers and impact in TTR levels, A-Beta peptide transport and uptake
PTDC/MED-PAT/0959/2021
Bolseiro de Cientista Convidado
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia

Projeto

Designação Financiadores
2011/07/01 - Atual The GENetic Frontotemporal Dementia Initiative (GENFI): a new multi-centre platform for the study of frontotemporal lobar degeneration
info:eu-repo/grantAgreement/RCUK/MRC/MR2%FJ0094822%F1/GB
University College London Institute of Neurology, Reino Unido
 Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung
Em curso

Outro

Designação Financiadores
2017/10/01 - Atual Genetic and phenotype correlation of a Portuguese Dementia cohort
-
Bolseiro de Doutoramento
Em curso
Produções

Publicações

Artigo em revista
  1. Maria Rosário Almeida; Miguel Tábuas-Pereira; Inês Baldeiras; Marisa Lima; João Durães; João Massano; Madalena Pinto; Catarina Cruto; Isabel Santana. "Characterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia". International Journal of Molecular Sciences (2023): https://www.mdpi.com/1422-0067/25/1/511.
    10.3390/ijms25010511
  2. Catarina Bernardes; Marisa Lima; Diana Duro; Anuschka Silva-Spínola; João Durães; Miguel Tábuas-Pereira; Inês Baldeiras; Sandra Freitas; Isabel Santana. "Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia". Journal of Alzheimer's Disease (2023): http://dx.doi.org/10.3233/jad-230916.
    10.3233/jad-230916
  3. Randall J. Bateman; Janice Smith; Michael C. Donohue; Paul Delmar; Rachid Abbas; Stephen Salloway; Jakub Wojtowicz; et al. "Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease". New England Journal of Medicine (2023): http://dx.doi.org/10.1056/nejmoa2304430.
    10.1056/nejmoa2304430
  4. Abbe Ullgren; Linn Öijerstedt; Jennie Olofsson; Sofia Bergström; Julia Remnestål; John C. van Swieten; Lize C. Jiskoot; et al. "Altered plasma protein profiles in genetic FTD – a GENFI study". Molecular Neurodegeneration (2023): http://dx.doi.org/10.1186/s13024-023-00677-6.
    10.1186/s13024-023-00677-6
  5. J. Durães; P. Marques; A.M. Novo; J. Facas; D. Duro; M. Lima; M.J. Leitão; et al. "Associations between self-reported sleep quality and cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease". Revue Neurologique (2023): http://dx.doi.org/10.1016/j.neurol.2022.12.009.
    10.1016/j.neurol.2022.12.009
  6. Pedro Lopes das Neves; João Durães; Anuschka Silva-Spinola; Marisa Lima; Maria João Leitão; Miguel Tábuas-Pereira; Isabel Santana; Inês Baldeiras. "Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center". Journal of Alzheimer's Disease (2023): http://dx.doi.org/10.3233/jad-221208.
    10.3233/jad-221208
  7. Kiran Samra; Amy M. MacDougall; Arabella Bouzigues; Martina Bocchetta; David M. Cash; Caroline V. Greaves; Rhian S. Convery; et al. "Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort". Journal of the Neurological Sciences (2023): http://dx.doi.org/10.1016/j.jns.2023.120711.
    10.1016/j.jns.2023.120711
  8. Anuschka Silva-Spinola; Marisa Lima; Maria João Leitão; Catarina Bernardes; João Durães; Diana Duro; Miguel Tábuas-Pereira; Isabel Santana; Inês Baldeiras. "Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia". European Journal of Neurology (2023): http://dx.doi.org/10.1111/ene.15762.
    10.1111/ene.15762
  9. Elizabeth Finger; Rubina Malik; Martina Bocchetta; Kristy Coleman; Caroline Graff; barbara borroni; Mario Masellis; et al. "Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers". Brain (2023): http://dx.doi.org/10.1093/brain/awac446.
    10.1093/brain/awac446
  10. Kiran Samra; Amy Macdougall; Georgia Peakman; Arabella Bouzigues; Martina Bocchetta; David M Cash; Caroline V Greaves; et al. "Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales". Journal of Neurology, Neurosurgery & Psychiatry (2023): http://dx.doi.org/10.1136/jnnp-2022-330152.
    10.1136/jnnp-2022-330152
  11. Aurelie Bussy; Jake P. Levy; Tristin Best; Raihaan Patel; Lani Cupo; Tim Van Langenhove; Jørgen Erik Nielsen; et al. "Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia". Human Brain Mapping (2023): http://dx.doi.org/10.1002/hbm.26220.
    10.1002/hbm.26220
  12. David J. Whiteside; Maura Malpetti; P. Simon Jones; Boyd C. P. Ghosh; Ian Coyle-Gilchrist; John C. van Swieten; Harro Seelaar; et al. "Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia". Alzheimer's & Dementia (2023): http://dx.doi.org/10.1002/alz.12824.
    10.1002/alz.12824
  13. Enrico Premi; Marta Pengo; Irene Mattioli; Valentina Cantoni; Juergen Dukart; Roberto Gasparotti; Emanuele Buratti; et al. "Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study". Neurobiology of Disease (2023): http://dx.doi.org/10.1016/j.nbd.2023.106068.
    10.1016/j.nbd.2023.106068
  14. Kiran Samra; Amy M. MacDougall; Arabella Bouzigues; Martina Bocchetta; David M. Cash; Caroline V. Greaves; Rhian S. Convery; et al. "Language impairment in the genetic forms of behavioural variant frontotemporal dementia". Journal of Neurology (2023): http://dx.doi.org/10.1007/s00415-022-11512-1.
    10.1007/s00415-022-11512-1
  15. Martina Bocchetta; Emily G Todd; Arabella Bouzigues; David Cash; Jennifer M Nicholas; Rhian S Convery; Lucy L Russell; et al. "Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort". Brain Communications (2023): http://dx.doi.org/10.1093/braincomms/fcad061.
    10.1093/braincomms/fcad061
  16. Agnès Pérez-Millan; Sergi Borrego-Écija; John C. van Swieten; Lize Jiskoot; Fermin Moreno; Robert Laforce; Caroline Graff; et al. "Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study". Journal of Neurology (2023): http://dx.doi.org/10.1007/s00415-022-11435-x.
    10.1007/s00415-022-11435-x
  17. Kiran Samra; Amy M. MacDougall; Georgia Peakman; Arabella Bouzigues; Martina Bocchetta; David M. Cash; Caroline V. Greaves; et al. "Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales". Journal of Neurology (2023): http://dx.doi.org/10.1007/s00415-022-11442-y.
    10.1007/s00415-022-11442-y
  18. João André Sousa; Catarina Bernardes; Sara Bernardo-Castro; Miguel Lino; Inês Albino; Lino Ferreira; José Brás; et al. "Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target". Frontiers in Aging Neuroscience (2023): http://dx.doi.org/10.3389/fnagi.2023.1102809.
    10.3389/fnagi.2023.1102809
  19. Marisa Lima; Miguel Tábuas-Pereira; João Durães; Daniela Vieira; Pedro Faustino; Inês Baldeiras; Isabel Santana. "Neuropsychological Assessment in the Distinction Between Biomarker Defined Frontal-Variant of Alzheimer’s Disease and Behavioral-Variant of Frontotemporal Dementia". Journal of Alzheimer's Disease (2023): http://dx.doi.org/10.3233/jad-220897.
    10.3233/jad-220897
  20. Enrico Premi; Marcello Giunta; Armin Iraji; Srinivas Rachakonda; VinceD. Calhoun; Stefano Gazzina; Alberto Benussi; et al. "Corrigendum to “Dissemination in time and space in presymptomatic granulin mutation carriers: A spatial chronnectome study” [Neurobiology of Aging Volume 108, December 2021, Pages 155–167]". Neurobiology of Aging (2022): http://dx.doi.org/10.1016/j.neurobiolaging.2022.08.005.
    10.1016/j.neurobiolaging.2022.08.005
  21. Ione O. C. Woollacott; Imogen J. Swift; Aitana Sogorb-Esteve; Carolin Heller; Kathryn Knowles; Arabella Bouzigues; Lucy Russell; et al. "CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia". Annals of Clinical and Translational Neurology (2022): http://dx.doi.org/10.1002/acn3.51672.
    10.1002/acn3.51672
  22. Inês Baldeiras; Anuschka Silva-Spínola; Marisa Lima; Maria João Leitão; João Durães; Daniela Vieira; Miguel Tábuas-Pereira; et al. "Alzheimer’s Disease Diagnosis Based on the Amyloid, Tau, and Neurodegeneration Scheme (ATN) in a Real-Life Multicenter Cohort of General Neurological Centers". Journal of Alzheimer's Disease (2022): http://dx.doi.org/10.3233/jad-220587.
    10.3233/jad-220587
  23. Adam Staffaroni; Melanie Quintana; Barbara Wendelberger; Hilary W. Heuer; Lucy Russell; Yann Cobigo; Amy Wolf; et al. "Temporal order of clinical and biomarker changes in familial frontotemporal dementia". Nature Medicine (2022): http://dx.doi.org/10.1038/s41591-022-01942-9.
    10.1038/s41591-022-01942-9
  24. Miguel Tábuas-Pereira; Rita Guerreiro; Celia Kun-Rodrigues; Maria Almeida; Jose Bras; Isabel Santana. "Whole-exome sequencing reveals PSEN1 and ATP7B combined variants as a possible cause of early-onset Lewy body dementia: a case study of genotype–phenotype correlation". neurogenetics (2022): http://dx.doi.org/10.1007/s10048-022-00699-0.
    10.1007/s10048-022-00699-0
  25. Emma L. van der Ende; Carolin Heller; Aitana Sogorb-Esteve; Imogen J. Swift; David McFall; Georgia Peakman; Arabella Bouzigues; et al. "Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study". Journal of Neuroinflammation (2022): http://dx.doi.org/10.1186/s12974-022-02573-0.
    10.1186/s12974-022-02573-0
  26. Aitana Sogorb-Esteve; Johanna Nilsson; Imogen J. Swift; Carolin Heller; Martina Bocchetta; Lucy L. Russell; Georgia Peakman; et al. "Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia". Alzheimer's Research & Therapy (2022): http://dx.doi.org/10.1186/s13195-022-01042-3.
    10.1186/s13195-022-01042-3
  27. Annabel Nelson; Lucy Russell; Georgia Peakman; Rhian S. Convery; Arabella Bouzigues; Caroline V. Greaves; Martina Bocchetta; et al. "The CBI-R detects early behavioural impairment in genetic frontotemporal dementia". Annals of Clinical and Translational Neurology (2022): http://dx.doi.org/10.1002/acn3.51544.
    10.1002/acn3.51544
  28. Premi, Enrico; Costa, Tommaso; Gazzina, Stefano; Benussi, Alberto; Cauda, Franco; Gasparotti, Roberto; Archetti, Silvana; et al. "An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers". Journal of Alzheimer's Disease 86 1 (2022): 205-218. http://dx.doi.org/10.3233/jad-215447.
    10.3233/jad-215447
  29. Tábuas-Pereira, Miguel; Santana, Isabel; Almeida, Maria Rosário; Durães, João; Lima, Marisa; Duro, Diana; Kun-Rodrigues, Célia; Bras, Jose; Guerreiro, Rita. "Rare variants in TP73 in a frontotemporal dementia cohort link this gene with primary progressive aphasia phenotypes". European Journal of Neurology (2022): http://dx.doi.org/10.1111/ene.15248.
    10.1111/ene.15248
  30. Poos, Jackie M.; Moore, Katrina M.; Nicholas, Jennifer; Russell, Lucy L.; Peakman, Georgia; Convery, Rhian S.; Jiskoot, Lize C.; et al. "Cognitive composites for genetic frontotemporal dementia: GENFI-Cog". Alzheimer's Research & Therapy 14 1 (2022): http://dx.doi.org/10.1186/s13195-022-00958-0.
    10.1186/s13195-022-00958-0
  31. Marisa Lima; Miguel Tábuas-Pereira; João Durães; Pedro Faustino; Mário R. Simões; Walter Kukull; David S. Knopman; Isabel Santana. "Portuguese version of the CDR plus NACC FTLD: Validation studies". Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (2022): http://dx.doi.org/10.1002/dad2.12355.
    10.1002/dad2.12355
  32. Wilke, Carlo; Reich, Selina; Swieten, John C.; Borroni, Barbara; Sanchez-Valle, Raquel; Moreno, Fermin; Laforce, Robert; et al. "Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study". Annals of Neurology 91 1 (2021): 33-47. http://dx.doi.org/10.1002/ana.26265.
    10.1002/ana.26265
  33. Bergström, Sofia; Öijerstedt, Linn; Remnestål, Julia; Olofsson, Jennie; Ullgren, Abbe; Seelaar, Harro; van Swieten, John C.; et al. "A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study". Molecular Neurodegeneration 16 1 (2021): http://dx.doi.org/10.1186/s13024-021-00499-4.
    10.1186/s13024-021-00499-4
  34. Silva-Spínola, Anuschka; Lima, Marisa; Leitão, Maria João; Durães, João; Tábuas-Pereira, Miguel; Almeida, Maria Rosário; Santana, Isabel; Baldeiras, Inês. "Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia". European Journal of Neurology 29 1 (2021): 36-46. http://dx.doi.org/10.1111/ene.15058.
    10.1111/ene.15058
  35. Öijerstedt, Linn; Andersson, Christin; Jelic, Vesna; van Swieten, John Cornelis; Jiskoot, Lize C; Seelaar, Harro; Borroni, Barbara; et al. "Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study". Journal of Neurology, Neurosurgery & Psychiatry 93 3 (2021): 336-339. http://dx.doi.org/10.1136/jnnp-2021-327005.
    10.1136/jnnp-2021-327005
  36. Peakman, Georgia; Russell, Lucy L; Convery, Rhian S; Nicholas, Jennifer M; Van Swieten, John C; Jiskoot, Lize C; Moreno, Fermin; et al. "Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort". Journal of Neurology, Neurosurgery & Psychiatry 93 2 (2021): 158-168. http://dx.doi.org/10.1136/jnnp-2021-326868.
    10.1136/jnnp-2021-326868
  37. Franklin, Hannah D.; Russell, Lucy L.; Peakman, Georgia; Greaves, Caroline V.; Bocchetta, Martina; Nicholas, Jennifer; Poos, Jackie; et al. "The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort". Alzheimer's Research & Therapy 13 1 (2021): http://dx.doi.org/10.1186/s13195-021-00865-w.
    10.1186/s13195-021-00865-w
  38. Tábuas-Pereira, Miguel; Galego, Orlando; Almeida, Maria Rosário; Tomás, José; Félix-Morais, Ricardo; Silva, Fernando; Rodrigues, Bruno; Cordeiro, Gustavo; Sargento-Freitas, João. "Apolipoprotein E genotype does not influence the risk of symptomatic hemorrhage in acute ischemic stroke". Journal of Clinical Neuroscience 88 (2021): 34-38. http://dx.doi.org/10.1016/j.jocn.2021.03.014.
    10.1016/j.jocn.2021.03.014
  39. Lima, Marisa; Baeta, Élia; Duro, Diana; Tábuas-Pereira, Miguel; Valério, Daniela; Freitas, Sandra; Simões, Mário R.; Santana, Isabel. "Toulouse-Piéron Cancellation Test: Normative scores for the portuguese population". Applied Neuropsychology: Adult (2021): 1-7. http://dx.doi.org/10.1080/23279095.2021.1918694.
    10.1080/23279095.2021.1918694
  40. Manera, Ana L; Dadar, Mahsa; Van Swieten, John Cornelis; Borroni, Barbara; Sanchez-Valle, Raquel; Moreno, Fermin; Laforce Jr, Robert; et al. "MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia". Journal of Neurology, Neurosurgery & Psychiatry 92 6 (2021): 608-616. http://dx.doi.org/10.1136/jnnp-2020-324106.
    10.1136/jnnp-2020-324106
  41. Panman, Jessica L; Venkatraghavan, Vikram; van der Ende, Emma L; Steketee, Rebecca M E; Jiskoot, Lize C; Poos, Jackie M; Dopper, Elise G P; et al. "Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia". Journal of Neurology, Neurosurgery & Psychiatry (2021): jnnp-2020. http://dx.doi.org/10.1136/jnnp-2020-323541.
    10.1136/jnnp-2020-323541
  42. Cuffaro, Luca; Carvalho, Vanessa; Di Liberto, Giovanni; Klinglehoefer, Lisa; Sauerbier, Anna; Garcia-Azorin, David; Tábuas-Pereira, Miguel; et al. "Neurology training and research in the COVID-19 pandemic: a survey of the Resident and Research Fellow Section of the European Academy of Neurology". European Journal of Neurology (2021): http://dx.doi.org/10.1111/ene.14696.
    10.1111/ene.14696
  43. Benussi, Alberto; Premi, Enrico; Gazzina, Stefano; Brattini, Chiara; Bonomi, Elisa; Alberici, Antonella; Jiskoot, Lize; et al. "Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia". JAMA Network Open 4 1 (2021): e2030194. http://dx.doi.org/10.1001/jamanetworkopen.2020.30194.
    10.1001/jamanetworkopen.2020.30194
  44. Poos, Jackie M.; Russell, Lucy L.; Peakman, Georgia; Bocchetta, Martina; Greaves, Caroline V.; Jiskoot, Lize C.; Ende, Emma L.; et al. "Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study". Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 1 (2021): http://dx.doi.org/10.1002/dad2.12185.
    10.1002/dad2.12185
  45. Tábuas-Pereira, Miguel; Lima, Marisa; Duro, Diana; Durães, João; Vieira, Daniela; Baldeiras, Inês; Almeida, MariaRosário; Santana, Isabel. "Neuropsychological features of progranulin-associated frontotemporal dementia: a nested case-control study". Neural Regeneration Research 16 5 (2021): 910. http://dx.doi.org/10.4103/1673-5374.297082.
    10.4103/1673-5374.297082
  46. Borrego-Écija, Sergi; Sala-Llonch, Roser; van Swieten, John; Borroni, Barbara; Moreno, Fermín; Masellis, Mario; Tartaglia, Carmela; et al. "Disease-related cortical thinning in presymptomatic granulin mutation carriers". NeuroImage: Clinical 29 (2021): 102540. http://dx.doi.org/10.1016/j.nicl.2020.102540.
    10.1016/j.nicl.2020.102540
  47. Bocchetta, Martina; Todd, Emily G.; Peakman, Georgia; Cash, David M.; Convery, Rhian S.; Russell, Lucy L.; Thomas, David L.; et al. "Differential early subcortical involvement in genetic FTD within the GENFI cohort". NeuroImage: Clinical 30 (2021): 102646. http://dx.doi.org/10.1016/j.nicl.2021.102646.
    10.1016/j.nicl.2021.102646
  48. Monteiro, Ana; Velon, Ana Graça; Rodrigues, Ana Margarida; Oliveira, Ana; Valadas, Anabela; Nóbrega, Camila; Cruto, Catarina; et al. "Consenso Português para o Diagnóstico e Gestão Clínica da Demência com Corpos de Lewy (PORTUCALE)". Acta Médica Portuguesa 33 12 (2020): 844. http://dx.doi.org/10.20344/amp.13696.
    10.20344/amp.13696
  49. Russell, Lucy L.; Greaves, Caroline V.; Bocchetta, Martina; Nicholas, Jennifer; Convery, Rhian S.; Moore, Katrina; Cash, David M.; et al. "Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort". Cortex 133 (2020): 384-398. http://dx.doi.org/10.1016/j.cortex.2020.08.023.
    10.1016/j.cortex.2020.08.023
  50. Tábuas-Pereira, Miguel. "Incidental findings in peer neurological examination". Journal of the Neurological Sciences (2020): http://dx.doi.org/10.1016/j.jns.2020.117065.
    10.1016/j.jns.2020.117065
  51. Tábuas-Pereira, Miguel. "C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia". Experimental Gerontology (2020): http://dx.doi.org/10.1016/j.exger.2020.111004.
    10.1016/j.exger.2020.111004
  52. Tábuas-Pereira, Miguel. "Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort". Journal of Neurology, Neurosurgery & Psychiatry (2020): http://dx.doi.org/10.1136/jnnp-2020-323279.
    10.1136/jnnp-2020-323279
  53. Tábuas-Pereira, Miguel. "CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort". Brain (2020): http://dx.doi.org/10.1093/brain/awaa183.
    10.1093/brain/awaa183
  54. Tábuas-Pereira, Miguel. "Face-Specific Perceptual Distortions Reveal A View- and Orientation-Independent Face Template". Current Biology (2020): http://dx.doi.org/10.1016/j.cub.2020.07.067.
    10.1016/j.cub.2020.07.067
  55. Tábuas-Pereira, Miguel. "Genetic architecture of common non-Alzheimer’s disease dementias". Neurobiology of Disease (2020): http://dx.doi.org/10.1016/j.nbd.2020.104946.
    10.1016/j.nbd.2020.104946
  56. Tábuas-Pereira, Miguel. "Neuropsychological profile of amyloid-positive versus amyloid-negative amnestic Mild Cognitive Impairment". Journal of Neuropsychology (2020): http://dx.doi.org/10.1111/jnp.12218.
    10.1111/jnp.12218
  57. Tábuas-Pereira, Miguel. "Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers". Annals of Neurology (2020): http://dx.doi.org/10.1002/ana.25748.
    10.1002/ana.25748
  58. van der Ende, Emma L; Xiao, Meifang; Xu, Desheng; Poos, Jackie M; Panman, Jessica L; Jiskoot, Lize C; Meeter, Lieke H; et al. "Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia". Journal of Neurology, Neurosurgery & Psychiatry (2020): jnnp-2019. http://dx.doi.org/10.1136/jnnp-2019-322493.
    Publicado • 10.1136/jnnp-2019-322493
  59. Pereira, Miguel; Durães, João; Macário, Maria do Carmo. "Two sisters with myoclonus and ataxia". Practical Neurology (2020): practneurol-2019. http://dx.doi.org/10.1136/practneurol-2019-002446.
    10.1136/practneurol-2019-002446
  60. Tábuas-Pereira, Miguel. "Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia". Journal of Neurology, Neurosurgery & Psychiatry (2020): http://dx.doi.org/10.1136/jnnp-2019-321954.
    10.1136/jnnp-2019-321954
  61. Tábuas-Pereira, Miguel; Santana, Isabel; Guerreiro, Rita; Brás, José. "Alzheimer’s Disease Genetics: Review of Novel Loci Associated with Disease". Current Genetic Medicine Reports 8 1 (2020): 1-16. http://dx.doi.org/10.1007/s40142-020-00182-y.
    10.1007/s40142-020-00182-y
  62. Tábuas-Pereira, Miguel. "Single Word Repetition Predicts Long-Term Outcome of Aphasia Caused by an Ischemic Stroke". Journal of Stroke and Cerebrovascular Diseases (2020): http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2019.104566.
    10.1016/j.jstrokecerebrovasdis.2019.104566
  63. Tábuas-Pereira, Miguel. "Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study". The Lancet Neurology (2020): http://dx.doi.org/10.1016/s1474-4422(19)30394-1.
    10.1016/s1474-4422(19)30394-1
  64. Tábuas-Pereira, Miguel; Almeida, Maria Rosário; Duro, Diana; Lima, Marisa; Durães, João; Guerreiro, Rita; Brás, José; Baldeiras, Inês; Santana, Isabel. "Patients with progranulin mutations overlap with the progressive dysexecutive syndrome: towards the definition of a frontoparietal dementia phenotype". Brain Communications 2 2 (2020): http://dx.doi.org/10.1093/braincomms/fcaa126.
    10.1093/braincomms/fcaa126
  65. van der Ende, Emma L; Meeter, Lieke H; Poos, Jackie M; Panman, Jessica L; Jiskoot, Lize C; Dopper, Elise G P; Papma, Janne M; et al. "Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study". The Lancet Neurology 18 12 (2019): 1103-1111. http://dx.doi.org/10.1016/s1474-4422(19)30354-0.
    10.1016/s1474-4422(19)30354-0
  66. Daniela Vieira; João Durães; Inês Baldeiras; Beatriz Santiago; Diana Duro; Marisa Lima; Maria João Leitão; Miguel Tábuas-Pereira; Isabel Santana. "Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia". Diagnostics (2019): https://www.mdpi.com/2075-4418/9/4/162.
    10.3390/diagnostics9040162
  67. Tábuas-Pereira, Miguel. "Increased CSF tau is associated with a higher risk of seizures in patients with Alzheimer's disease". Epilepsy & Behavior (2019): http://dx.doi.org/10.1016/j.yebeh.2019.06.033.
    10.1016/j.yebeh.2019.06.033
  68. Tábuas-Pereira, Miguel. "Education modulates brain maintenance in presymptomatic frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2019): https://doi.org/10.1136/jnnp-2019-320439.
    10.1136/jnnp-2019-320439
  69. Tábuas-Pereira, Miguel. "The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint.". NeuroImage (2019): https://doi.org/10.1016/j.neuroimage.2019.01.080.
    10.1016/j.neuroimage.2019.01.080
  70. Tábuas-Pereira, Miguel. "Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia.". Neurobiology of aging (2019): http://europepmc.org/articles/PMC6491498.
    10.1016/j.neurobiolaging.2018.12.009
  71. Tábuas-Pereira, Miguel. "Increased risk of melanoma in C9ORF72 repeat expansion carriers: A case-control study.". Muscle & nerve (2018): https://doi.org/10.1002/mus.26383.
    10.1002/mus.26383
  72. Tábuas-Pereira, Miguel. "Discriminative capacity and construct validity of the Clock Drawing Test in Mild Cognitive Impairment and Alzheimer's disease.". The Clinical neuropsychologist (2018): https://doi.org/10.1080/13854046.2018.1532022.
    10.1080/13854046.2018.1532022
  73. Tábuas-Pereira, Miguel. "The Head Turning Sign in Dementia and Mild Cognitive Impairment: Its Relationship to Cognition, Behavior, and Cerebrospinal Fluid Biomarkers.". Dementia and geriatric cognitive disorders (2018): https://doi.org/10.1159/000486531.
    10.1159/000486531
  74. Tábuas-Pereira, Miguel. "[Aphasia Rapid Test: Translation, Adaptation and Validation Studies for the Portuguese Population].". Acta medica portuguesa (2018): https://doi.org/10.20344/amp.9090.
    10.20344/amp.9090
  75. Tábuas-Pereira, Miguel. "Validity and Clinical Utility of Different Clock Drawing Test Scoring Systems in Multiple Forms of Dementia.". Journal of geriatric psychiatry and neurology (2018): https://doi.org/10.1177/0891988718774432.
    10.1177/0891988718774432
  76. Tábuas-Pereira, Miguel. "Addition of the Aß42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment.". Alzheimer's research & therapy (2018): http://europepmc.org/articles/PMC5861634.
    10.1186/s13195-018-0362-2
  77. Tábuas-Pereira, Miguel. "Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog): Normative Data for the Portuguese Population.". Acta medica portuguesa (2018): https://doi.org/10.20344/amp.8859.
    10.20344/amp.8859
  78. Tábuas-Pereira, Miguel. "Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration.". Journal of Alzheimer's disease : JAD (2018): https://doi.org/10.3233/JAD-179908.
    10.3233/jad-179908
  79. Tábuas-Pereira, Miguel. "Neurosonology Accuracy for Isolated Acute Vestibular Syndromes". Journal of Ultrasound in Medicine (2017): http://dx.doi.org/10.1002/jum.14301.
    10.1002/jum.14301
  80. Tábuas-Pereira, Miguel. "Intracranial Internal Carotid Artery Wall Calcification in Ischemic Strokes Treated with Thrombolysis.". European neurology (2017): https://doi.org/10.1159/000477901.
    10.1159/000477901
  81. Tábuas-Pereira, Miguel. "Clinical Reasoning: A 55-year-old man with rapidly progressive dementia and parkinsonism.". Neurology (2017): https://doi.org/10.1212/WNL.0000000000004495.
    10.1212/wnl.0000000000004495
  82. Tábuas-Pereira, Miguel. "European Academy of Neurology - Resident and Research Fellow Section: innovations and future direction in 2017.". European journal of neurology (2017): https://doi.org/10.1111/ene.13352.
    10.1111/ene.13352
  83. Tábuas-Pereira, Miguel. "Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.". Neuroscience letters (2017): https://doi.org/10.1016/j.neulet.2017.01.036.
    10.1016/j.neulet.2017.01.036
  84. Tábuas-Pereira, Miguel. "Tremor Frequency Assessment by iPhone® Applications: Correlation with EMG Analysis.". Journal of Parkinson's disease (2016): https://doi.org/10.3233/JPD-160936.
    10.3233/jpd-160936
  85. Tábuas-Pereira, Miguel. "Prosopagnosia as the Presenting Symptom of Whipple Disease.". Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology (2016): https://doi.org/10.1097/WNN.0000000000000091.
    10.1097/wnn.0000000000000091
  86. Tábuas-Pereira, Miguel. "[Mini-Mental State Examination: Screening and Diagnosis of Cognitive Decline, Using New Normative Data].". Acta medica portuguesa (2016): https://doi.org/10.20344/amp.6889.
    10.20344/amp.6889
  87. Tábuas-Pereira, Miguel. "Prognosis of Early-Onset vs. Late-Onset Mild Cognitive Impairment: Comparison of Conversion Rates and Its Predictors". Geriatrics (2016): http://www.mdpi.com/2308-3417/1/2/11.
    10.3390/geriatrics1020011
  88. Tábuas-Pereira, Miguel. "Biparietal variant of Alzheimer's disease: a rare presentation of a common disease.". BMJ case reports (2015): http://europepmc.org/articles/PMC4289771.
    10.1136/bcr-2014-207011
Poster em conferência
  1. Tábuas-Pereira, Miguel. "Early infection and single word repetition predict post-stroke aphasia long term outcome". Trabalho apresentado em 4th European Stroke Organization Conference, 2018.
  2. Tábuas-Pereira, Miguel; Ricardo Varela; Jose Coelho; Diogo Maleita; Carlos Ferreira; Otilia C. d'Almeida; César Nunes; Isabel Luzeiro; Gustavo Cordeiro Santo. "Headache intensity is associated with increased white matter lesion burden in CADASIL patients". Trabalho apresentado em 4th Congress of the European Academy of Neurology, 2018.
    10.1016/j.jocn.2019.11.025
  3. Tábuas-Pereira, Miguel. "SQSTM1 mutations associated with Lewy body dementia". Trabalho apresentado em 4th Congress of the European Academy of Neurology, 2018.
  4. Tábuas-Pereira, Miguel. "Neuropsychiatric symptoms in Mild Cognitive Impairment: biological determinants and prediction of conversion". Trabalho apresentado em 4th Congress of the European Academy of Neurology, 2018.
  5. Tábuas-Pereira, Miguel. "Neuropsychiatric symptoms in variants of Primary Progressive Aphasia (PPA)". Trabalho apresentado em 4th Congress of the European Academy of Neurology, 2018.
  6. Tábuas-Pereira, Miguel. "Migraine Prophylaxis in a sample of migraine patients referred to the headache consultation". Trabalho apresentado em 4th Congress of the European Academy of Neurology, 2018.
  7. Tábuas-Pereira, Miguel. "Genetic Analysis of a dementia patients’ cohort: experience from Coimbra center in Portugal". Trabalho apresentado em 4th Congress of the European Academy of Neurology, 2018.
  8. Tábuas-Pereira, Miguel. "Quality of life in adult patients with leukodystrophies: the impact of perceived fatigue". Trabalho apresentado em 13th International Congress on Inborn Errors of Metabolism, 2017.
  9. Tábuas-Pereira, Miguel. "A novel mutation in collagen XII causing Ullrich-like muscular dystrophy". Trabalho apresentado em 3rd Congress of the European Academy of Neurology, 2017.
  10. Tábuas-Pereira, Miguel. "ApoE genotype and the outcome of thrombolysis in acute ischemic stroke". Trabalho apresentado em 3rd Congress of the European Academy of Neurology., 2017.
  11. Tábuas-Pereira, Miguel. "The burden of physical and cognitive fatigue in Multiple Sclerosis". Trabalho apresentado em 3rd Congress of the European Academy of Neurology, 2017.
  12. Tábuas-Pereira, Miguel. "Two siblings with action myoclonus renal failure syndrome". Trabalho apresentado em 20th International Congress of Parkinson's Disease and Movement Disorders, 2016.
  13. Tábuas-Pereira, Miguel. "PET examinations of the monoamine transporter with 11C-Beta-CIT". Trabalho apresentado em 20th International Congress of Parkinson's Disease and Movement Disorders, 2016.
  14. Tábuas-Pereira, Miguel. "Apraxia in Parkinson's Disease". Trabalho apresentado em 20th International Congress of Parkinson's Disease and Movement Disorders, 2016.
  15. Tábuas-Pereira, Miguel. "Tremor Frequency by iPhone® applications: Correlation with EMG analysis". Trabalho apresentado em 20th International Congress of Parkinson's Disease and Movement Disorders, 2016.
  16. Tábuas-Pereira, Miguel. "Increased risk of melanoma in c9orf72 repeat expansion carriers". Trabalho apresentado em 4th Congress of the European Academy of Neurology, 2016.
  17. Tábuas-Pereira, Miguel. "Going to the root of the problem: Horner syndrome caused by T1-T2 disc herniation". Trabalho apresentado em 2nd Congress of the European Academy of Neurology2nd Congress of the European Academy of Neurology, 2016.
  18. Fišic, Martina; Šimic, Jelena; Tuškan-Mohar, Lidija. "Neurosonology for the diagnosis of stroke in isolated acute vestibular syndromes". Trabalho apresentado em 2nd Congress of the European Academy of Neurology, 2016.
    10.17486/gyr.3.2221
  19. Tábuas-Pereira, Miguel. "The Clock Drawing Test as a cognitive screening instrument: development of Portuguese normative data for the Mini-Mental State Examination + Clock Drawing combination". Trabalho apresentado em 2nd Congress of the European Academy of Neurology, 2016.
  20. Tábuas-Pereira, Miguel. "Late-onset Krabbe disease in an adult metabolic disorders consultation". Trabalho apresentado em 2nd Congress of the European Academy of Neurology, 2016.
  21. Tábuas-Pereira, Miguel. "The role of pre-morbid intelligence in Clock Drawing Test: studies with the portuguese irregular word reading test". Trabalho apresentado em 2nd Congress of the European Academy of Neurology, 2016.
  22. Tábuas-Pereira, Miguel. "Migraine and hypnic headache: an age-related sleep continuum?". Trabalho apresentado em 23rd Congress of the European Sleep Research Society, 2016.
  23. Tábuas-Pereira, Miguel. "Validation Studies of the Clock Drawing Test in mild cognitive impairment". Trabalho apresentado em A case of leukoencephalopathy, cerebral calcifications and cysts - Labrune Syndrome, 2015.
  24. Tábuas-Pereira, Miguel. "Hemiprosopometamorphopsia as the presenting symptom of Marchiafava-Bignami disease". Trabalho apresentado em 1st Congress of the European Academy of Neurology, 2015.
  25. Tábuas-Pereira, Miguel. "Clock drawing test: validation studies with multiple forms of dementia". Trabalho apresentado em Joint Congress of European Neurology, 2015.
  26. Tábuas-Pereira, Miguel. "Neurodegeneration with Brain Iron Accumulation type I: clinical, genetic, radiographic delineation and impact on quality of life". Trabalho apresentado em 1st Congress of the European Academy of Neurology, 2015.
  27. Tábuas-Pereira, Miguel. "Previous treatment with angiotensin converting enzyme inhibitors in patients with ischemic stroke submitted to intravenous thrombolysis". Trabalho apresentado em 1st European Stroke Organization Conference, 2015.
  28. Tábuas-Pereira, Miguel. "Hemodynamic impact of carotid siphon wall calcification in intravenous thrombolysis". Trabalho apresentado em 20th Meeting of the European Society of Neurosonology and Cerebral Hemodynamics, 2015.
  29. Tábuas-Pereira, Miguel. "Montreal Cognitive Assessment (MoCA) in Mild Cognitive Impairment: correlation with cerebral perfusion in SPECT". Trabalho apresentado em Joint Congress of European Neurology, 2015.
  30. Tábuas-Pereira, Miguel. "Spontaneous periodic hypothermia: differential diagnosis and treatment of a very rare condition". Trabalho apresentado em Joint Congress of European Neurology, 2014.
Resumo em conferência
  1. Tábuas-Pereira, Miguel; João Durães; Rui Araújo; Sandra Bernardino; Diana Duro; Isabel Santana. "The head turning sign in Alzheimer's Disease in relationship with cognitive impairment and CSF biomarkers". Trabalho apresentado em 2nd Congress of the European Academy of Neurology, Copenahga, 2016.
  2. Tábuas-Pereira, Miguel. "Montreal Cognitive Assessment in mild cognitive impairment: correlation with cerebrospinal fluid biomarkers and prediction of conversion to dementia". Trabalho apresentado em 2nd Congress of the European Academy of Neurology, Copenhaga, 2016.
Atividades

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2021/01/01 - 2025/12/31 A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
2021/10/01 - 2024/12/31 WHO Global Dementia Observatory Knowledge Exchange (GDO KE) Platform peer reviewer Organisation mondiale de la Santé, Suiça

Membro de associação

Nome da associação Tipo de participação
2016/04/01 - 2020/06/30 Movement Disorders Society Member

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2016/09/01 - Atual Member of The Education Committee of the European Academy of Neurology
Membro
 European Academy of Neurology, Áustria
2016/09/01 - Atual Member of the Scientific Panel of Higher Cortical Functions
Membro
 European Academy of Neurology, Áustria
2022/01/01 - 2024/12/31 Coordinating Panel on Rare Neurological Diseases
Membro
 European Academy of Neurology, Áustria
2022/03/01 - 2024/03/30 Task Force to work on pre-graduate curriculum
Membro
 European Academy of Neurology, Áustria
2019/01/01 - 2020/06/30 Co-investigador no ensaio de fase III "Graduate II Study: Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2015/01/01 - 2020/06/30 Co-investigador no "The Genetic Frontotemporal dementia Initiative (GENF2I)" (colaboração internacional no seguimento de familiares de doentes com formas genéticas de demência frontotemporal para estudos dirigos à melhor compreensão desta doença)
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2017/01/01 - 2019/12/31 Clinical rater no ensaio de fase III "ASCLEPIOS-II: Efficacy and safety of Ofatumumab compared to Teriflunomide in patients with relapsing Multiple Sclerosis"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2016/01/01 - 2019/12/31 Clinical rater no ensaio de fase III "OPTIMUM: Oral Ponesimod versus Teriflunomide in Relapsing Multiple Sclerosis"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2015/01/01 - 2019/12/31 Clinical rater no ensaio de fase III "CBAF312A2201E1 EXPAND - Long-term safety, tolerability and efficacy of BAF312 given orally in patients with Relapsing-Remitting Multiple Sclerosis"
Outro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2018/10/31 - 2019/06/30 Co-investigador no ensaio clínico fase II/III "A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (Generation S2)"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2018/01/01 - 2019/04/30 Co-investigador no ensaio clínico de fase III "CREAD: A study of Crenezumab versus Placebo to evaluate the efficacy and safety in participants with prodromal to mild Alzheimer’s Disease"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2016/01/01 - 2019/03/31 Co-investigador no ensaio de fase III "ENGAGE: 221AD301 Phase 3 study of Aducanumab (BIIB037) in early Alzheimer’s Disease"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2015/01/01 - 2018/12/31 Clinical rater no ensaio de fase III "SUNBEAM - A phase 3, multi-Center, randomized, double-blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to Relapsing Multiple Sclerosis patients"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2015/01/01 - 2018/12/31 Clinical rater no ensaio de fase III "LTS6050: Long term Safety and Efficacy Study of Teruflonamide 7mg or 14mg in Patients with Relapsing-Remitting Multiple Sclerosis"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2017/01/01 - 2018/10/31 Co-investigador no ensaio de fase III "DAYBREAK-ALZ: A Study of Lanabecestat (LY3314814) in participants with mild Alzheimer's Disease dementia"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2015/01/01 - 2017/12/31 Clinical rater no ensaio de fase III "ORATORIO: A study of Ocrelizumab in patients with Primary Progressive Multiple Sclerosis"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2015/01/01 - 2017/12/31 Clinical rater no ensaio de fase III "ACROSS: FTY720 D2399: Long-term safety and tolerability of 0.5 mg Fingolimod (FTY720) in patients with relapsing forms of Multiple Sclerosis"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2014/01/01 - 2017/12/31 Co-investigador no ensaio de fase III "EPOCH: MK 8931-017 - An efficacy and safety trial of verubecestat in mild to moderate Alzheimer's Disease"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2014/01/01 - 2015/12/31 Clinical rater em ensaio clínico fase III - "CBAF312A2304 - A multicenter, randomized, double blind, parallel group, placebo controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis "
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2013/01/01 - 2014/12/31 Co-investigador em ensaio clínico fase III - "CL2-38093-011 - Efficacy and safety of S 38093 versus Placebo in patients with mild to moderate Alzheimer's Disease"
Membro
 Centro Hospitalar e Universitário de Coimbra EPE, Portugal
Distinções

Prémio

2005 Medalha de Ouro, Olimpíadas Iberoamericanas de Física
Olimpíadas Iberoamericanas de Física, Uruguai
2004 2.º lugar nas Olimpíadas Portuguesas de Física
Olimpíadas Portuguesas de Física, Portugal

Outra distinção

2004 Medalha de Bronze nas Olimpíadas Paulistas de Matemática
Sociedade Portuguesa de Matemática, Portugal